ArticleOphthalmology2019

Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis (Ophthalmology. 2018;125:1332-1343).

Darren Shu Jeng TingPubMed ↗Publisher ↗

No numbers read from the abstract.